vimarsana.com
Home
Live Updates
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Tri
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Tri
MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA
/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...
Related Keywords
Canada ,
Canadian ,
Miri Halperin Wernli ,
Exchange Commission ,
Company Annual Report On Form ,
Prnewswire Mind Medicine Mindmed Inc ,
Company Or Mindmed ,
Matthias Liechti At University Hospital Basel ,
Nasdaq ,
Medicine Mindmed Inc ,
Matthias Liechti ,
University Hospital Basel ,
Executive President ,
Visual Analog Scales ,
Altered States ,
Annual Report ,
Quarterly Reports ,
Note Regarding Forward Looking Statements ,
Financial Condition ,
Mind Medicine Mindmed Inc ,